Martin Naley

Martin Naley is an experienced professional in strategy and market development within the healthcare sector, currently serving at Prolaio since October 2022. Prior to this role, Martin was the Head of Product Innovation at Invitae, where significant contributions were made to improve patient access to medical records and facilitate clinical trial matching. Martin's expertise also includes consulting positions with various organizations, such as Thrive Earlier Detection Corp. and the Biden Cancer Initiative, focusing on cancer detection and clinical trials. As the Founding CEO of Cure Forward Corp., Martin developed an online precision medicine platform to empower patients in their healthcare journeys. Martin holds an MBA in Strategy and Leadership from Yale School of Management and a BA in Biological Sciences from Cornell University.